Fred Alger Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Fred Alger Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,000	Closed	-$549K	–	608
2017 Q4	$549K	Sell	12,000 -10,000	-45%	-$499K	﹤0.01%	366
2017 Q3	$987K	Buy	+22,000	New	+$750K	﹤0.01%	325
2016 Q3	–	Sell	-35,692	Closed	-$1.37M	–	558
2016 Q2	$1.37M	Sell	35,692 -2,705	-7%	-$112K	0.01%	300
2016 Q1	$1.46M	Sell	38,397 -96,913	-72%	-$3.38M	0.01%	344
2015 Q4	$5.95M	Sell	135,310 -36,577	-21%	-$1.81M	0.03%	235
2015 Q3	$6.99M	Buy	171,887 +83,775	+95%	+$3.67M	0.04%	238
2015 Q2	$4.7M	Buy	88,112 +6,484	+8%	+$344K	0.02%	314
2015 Q1	$4.95M	Sell	81,628 -70	-0.1%	-$3.4K	0.02%	344
2014 Q4	$4.27M	Buy	+81,698	New	+$3.66M	0.02%	342

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Fred Alger Management's JUNO Position: Q1 2018 in Review

Fred Alger Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 12,000 shares — an estimated $549K sold.

Fred Alger Management first reported a position in JUNO in Q4 2014 and held it in 9 quarters. The position peaked at $6.99M in Q3 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Fred Alger Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Fred Alger Management sold 12,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $549K.
Fred Alger Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
Fred Alger Management's Juno Therapeutics, Inc. position peaked at $6.99M in Q3 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Fred Alger Management's 13F filing for Q1 2018, filed 10 May 2018.